Growth Metrics

ENDRA Life Sciences (NDRA) Current Leases (2019 - 2021)

Historic Current Leases for ENDRA Life Sciences (NDRA) over the last 3 years, with Q3 2021 value amounting to $127696.0.

  • ENDRA Life Sciences' Current Leases rose 7344.34% to $127696.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $127696.0, marking a year-over-year increase of 7344.34%. This contributed to the annual value of $76480.0 for FY2020, which is 1554.09% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Current Leases of $127696.0 as of Q3 2021, which was up 7344.34% from $123192.0 recorded in Q2 2021.
  • ENDRA Life Sciences' Current Leases' 5-year high stood at $127696.0 during Q3 2021, with a 5-year trough of $65295.0 in Q3 2019.
  • Its 3-year average for Current Leases is $83483.1, with a median of $73624.0 in 2020.
  • Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 1275.6% in 2020, then skyrocketed by 7344.34% in 2021.
  • Quarter analysis of 3 years shows ENDRA Life Sciences' Current Leases stood at $66193.0 in 2019, then grew by 15.54% to $76480.0 in 2020, then skyrocketed by 66.97% to $127696.0 in 2021.
  • Its Current Leases was $127696.0 in Q3 2021, compared to $123192.0 in Q2 2021 and $79175.0 in Q1 2021.